Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,831.74
+0.04280.00%
Number of Gainers:8
Number of Losers:11
Number of Flat:- -
PE:- -
High:1,847.82
Open:1,834.63
Low:1,827.63
Close:1,831.70
Volume:56.42M
Turnover:4.29B
Market Cap:1.49T
Float Cap:1.46T

Loading ...

American Tungsten & Antimony Taps Finland Firm for Scoping Study; Shares Up 4%

MT Newswires Live
·
Sep 01

Did Targeted XFG COVID Shots Just Recenter Pfizer's (PFE) Post‑Pandemic Investment Narrative?

Simply Wall St.
·
Sep 01

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Sep 01

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Abbott Laboratories Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Sep 01

Cboe data suggests bullish flow in Moderna with shares up 0.71%

TIPRANKS
·
Sep 01

Moderna Stock (MRNA) Was the Best Performer in August

TIPRANKS
·
Sep 01

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 01

Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization

TIPRANKS
·
Aug 31

China's Ascletis Pharma H1 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 31

Aethlon Medical Says All Pre-Funded Warrants are Exercised

Reuters
·
Aug 31

Abbott Laboratories Introduces Similac 360 Total Care Made With Whole Milk in US

MT Newswires Live
·
Aug 31

NanoViricides provides updateon Measles Drug Treatment Program

TIPRANKS
·
Aug 31

NanoViricides Drafts Phase II Trial Protocol for NV-387 Measles Treatment

Reuters
·
Aug 31

Abbott Launches the First and Only Ready-to-Feed Liquid Infant Formula Made with Whole Milk in the U.S. at Similar Price to Its Existing Similac Powdered Formula

THOMSON REUTERS
·
Aug 31

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

TIPRANKS
·
Aug 31

Hutchmed Says Lung Cancer Therapy Improves Progression-Free Survival in China Phase 3 Trial

MT Newswires Live
·
Aug 31

Analyst Warns of Significant Clinical and Regulatory Risks Facing Ibio Inc’s Drug Pipeline

TIPRANKS
·
Aug 31

CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial

Reuters
·
Aug 31